# Bionano Genomics, Inc. (BNGO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BNGO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 14.86M | $ -15.73M | $ -10.39M | $ 6.70M | $ 31.61M |
| 2025 | $ 29.19M | $ -27.03M | $ -16.74M | $ 6.92M | $ 44.42M |
| 2024 | $ 32.35M | $ -117.74M | $ -74.07M | $ 27.30M | $ 35.38M |
| 2023 | $ 39.05M | $ -251.38M | $ -137.18M | $ 79.41M | $ 96.16M |
| 2022 | $ 31.06M | $ -148.12M | $ -143.12M | $ 11.67M | $ 249.40M |
| 2021 | $ 21.37M | $ -86.10M | $ -87.23M | $ 10.70M | $ 337.12M |
| 2020 | $ 10.83M | $ -52.37M | $ -43.05M | $ 16.33M | $ 35.08M |
| 2019 | $ 13.07M | $ -38.48M | $ -38.19M | $ 20.08M | $ 3.61M |
| 2018 | $ 15.85M | $ -24.43M | $ -26.78M | $ 9.03M | $ 10.14M |
| 2017 | $ 12.80M | $ -31.48M | $ -29.42M | $ 6.73M | $ -50.23M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.21 |
| Liabilities / Eq | 0.51 |
| Current Ratio | 2.48 |

## Other views

- [Metrics](https://sponda.capital/en/BNGO.md)
- [Charts](https://sponda.capital/en/BNGO/charts.md)
- [Compare](https://sponda.capital/en/BNGO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.
